Results 11 to 20 of about 1,887 (161)
Chemical Stability of Telavancin in Elastomeric Pumps [PDF]
Current Therapeutic Research, 2015 Background: VIBATIV is a once-daily, injectable lipoglycopeptide antibiotic approved in the U.S. for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) caused by susceptible isolates of Staphylococcus aureus when
Patrick Sand, MSc +4 more
doaj +3 more sources
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions [PDF]
Current Therapeutic Research, 2015 Objective: The post-reconstitution chemical stability and microbial challenge hold time of nonpreserved telavancin for injection was determined using common reconstitution diluents and intravenous (IV) infusion solutions stored at room temperature with ...
Zhengtian Gu, PhD +5 more
doaj +3 more sources
Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections [PDF]
Infection and Drug Resistance, 2011 Lida Jafari Saraf, Samuel Eric Wilson21Veterans Administration Medical Center, Long Beach, CA, USA; 2Department of Surgery, University of California, Irvine, CA, USAAbstract: Telavancin, a novel lipoglycopeptide with rapid concentration-dependent ...
Lida Jafari Saraf, Samuel Eric Wilson
doaj +2 more sources
Update on the emerging role of telavancin in hospital-acquired infections
Therapeutics and Clinical Risk Management, 2015 Obinna N Nnedu,1 George A Pankey2 1Infectious Disease Department, Ochsner Clinic Foundation, New Orleans, LA, USA; 2Infectious Disease Research, Ochsner Clinic Foundation, New Orleans, LA, USA Abstract: Telavancin is a lipoglycopeptide that has ...
Nnedu ON, Pankey GA
doaj +3 more sources
Therapeutics and Clinical Risk Management, 2012 Candace Y Hooper, Winter J SmithDepartment of Pharmacy, Clinical and Administrative Sciences, University of Oklahoma Health Sciences Center College of Pharmacy, Oklahoma City, OK, USAAbstract: Telavancin is a bactericidal lipoglycopeptide antibiotic that
Hooper CY, Smith WJ
doaj +1 more source
Role of telavancin in treatment of skin and skin structure infections
Clinical, Cosmetic and Investigational Dermatology, 2010 Joseph Bonkowski1, Anne R Daniels2, William J Peppard21University of Wisconsin-Madison, Madison, WI, USA; 2Froedtert Hospital, Milwaukee, WI, USAAbstract: Skin and skin structure infections (SSSIs) are a common diagnosis encountered by ambulatory and ...
Joseph Bonkowski +2 more
doaj +2 more sources
A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)
Therapeutics and Clinical Risk Management, 2008 Lala M Dunbar1, Derek M Tang2, Robert M Manausa11Louisiana State University Health Sciences Center, New Orleans, USA; 2Tulane University School of Medicine, USAAbstract: Telavancin is a novel antibiotic being investigated for the treatment of serious ...
Lala M Dunbar +2 more
doaj +1 more source
Infection and Drug Resistance, 2014 Ethan Rubinstein,1 Martin E Stryjewski,2 Steven L Barriere31University of Manitoba, Winnipeg, MB, Canada; 2Department of Medicine, Section of Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos ...
Rubinstein E, Stryjewski ME, Barriere SL
doaj +1 more source
Pharmacokinetics and safety of a single dose of telavancin in pediatric subjects 2-17 years of age. [PDF]
Antimicrob Agents Chemother, 2023 Antimicrobial resistance increases infection morbidity in both adults and children, necessitating the development of new therapeutic options. Telavancin, an antibiotic approved in the United States for certain bacterial infections in adults, has not been
Bradley JS +5 more
europepmc +4 more sources
A review of antibiotic safety in pregnancy-2025 update. [PDF]
PharmacotherapyAbstract Antibiotics constitute the majority of prescriptions for women during pregnancy. Common bacterial infections, including urinary tract infections, skin and soft tissue infections, and upper and lower respiratory tract infections, are expected in pregnancy, similar to the general public.
Nguyen J +8 more
europepmc +2 more sources